SHS Capital

With their investments, they help shape European champions in their respective healthcare segments or support them in their further expansion.

In addition to capital, they essentially provide our networks and expertise in the areas of approval and reimbursement in the USA and China, marketing/sales, staffing and exit.

The focus of their investments is on holdings in the areas of medical technology, life sciences & services, diagnostics & tools and digital health. The geographical focus of their investments includes the DACH region as well as other selected European countries.

Their growth capital investments focus is on companies with market-ready products and technologies in order to develop them into market leaders in a joint partnership.

Hereby, SHS does not see itself as a technology scout or even a passive financial investor, but as a co-partner who brings not only capital, but also industry expertise and a long-standing network into a partnership. They are happy to invest in consortia together with private and institutional co-investors. In addition to classic capital increases, secondary transactions, e.g. of business angel shares, are also possible.

As Germany's leading growth investor, they are familiar with all challenges in the healthcare sector and bring to their partnerships not only many years of industry experience, but also synergy effects from our portfolio.

The company has raised €270 million for their sixth fund generation, with a focus on growing European healthcare companies. The new fund aims for ten to fifteen investments in the form of both majority and minority positions. The fund’s investment amount is €10 to €40 million.

Portfolio: AOS, Dr. Dropin, Lowenco, Mesi.